Hikma Pharmaceuticals PLC - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
HKMPY Over the counter 2830 www.hikma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Hikma Pharmaceuticals PLC

Why Hikma Pharmaceuticals (LSE:HIK) Analysts Are Reframing The Story With New Price Targets - Jan 22nd, 2026 10:08 pm
Par Health Names Dr. William Larkins as EVP and Chief Scientific Officer and President, Sterile Injectables - Jan 12th, 2026 6:00 am
Looking At The Narrative For Hikma Pharmaceuticals LSE HIK After Analyst Split On Fair Value - Jan 8th, 2026 9:11 am
Hikma Pharmaceuticals (LON:HIK) shareholders have endured a 29% loss from investing in the stock five years ago - Jan 6th, 2026 10:24 pm
How the Narrative Around Hikma Pharmaceuticals Is Shifting After Recent Analyst Target Moves - Dec 15th, 2025 5:09 am
Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US - Dec 8th, 2025 2:13 pm
How Recent Developments Are Shaping the Hikma Pharmaceuticals Story and Its Valuation - Nov 28th, 2025 2:37 pm
Why The Narrative Around Hikma Pharmaceuticals Is Shifting After Recent Analyst Updates - Nov 14th, 2025 12:13 am
Health Care Roundup: Market Talk - Nov 6th, 2025 3:30 pm
Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution - Oct 30th, 2025 6:23 am
How Recent Developments Are Rewriting the Story for Hikma Pharmaceuticals - Oct 30th, 2025 1:17 am
FTSE 100 hits another high despite concerns over US government shutdown - Oct 1st, 2025 10:30 am
Hikma Pharmaceuticals PLC (LON:HIK) is favoured by institutional owners who hold 59% of the company - Sep 19th, 2025 4:51 am
If EPS Growth Is Important To You, Hikma Pharmaceuticals (LON:HIK) Presents An Opportunity - Aug 26th, 2025 8:07 am
We bought this stock cheap and it’s getting cheaper - Aug 25th, 2025 10:00 pm
One Hikma Pharmaceuticals Insider Raised Stake By 14% In Previous Year - Aug 10th, 2025 2:26 am
[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - Aug 4th, 2025 10:30 pm
Hikma Pharmaceuticals (LON:HIK) shareholders have earned a 8.3% CAGR over the last three years - Jul 21st, 2025 8:32 am
Hikma receives FDA approval for TYZAVAN™ (Vancomycin Injection, USP) in the US - Jul 2nd, 2025 6:00 am
Trending tickers: Palantir, Boeing, UBS, WH Smith and Hikma Pharmaceuticals - Jun 30th, 2025 3:18 am